申请人:Ebdrup Soren
公开号:US20110003852A1
公开(公告)日:2011-01-06
Novel substituted benzamide based inhibitors, their use in therapy, pharmaceutical compositions comprising the compounds, the use of said compounds in the manufacture of medicaments, and therapeutic methods comprising the administration of said compounds are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, such as the metabolic syndrome.
本发明描述了一种基于新型取代苯甲酰胺的抑制剂,其在治疗中的使用,包括所述化合物的制药组合物,以及使用所述化合物制造药物和包括所述化合物的治疗方法。本发明化合物调节11β-羟基类固醇脱氢酶1型(11βHSD1)的活性,因此在治疗代谢综合症等有益调节的疾病中具有用途。